Back to search

Article

Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a Neddylation

2024-09-19

Abstract excerpt

<h4>Background</h4> Idiopathic Pulmonary fibrosis (IPF) is characterized by progressive scarring and fibrosis within the lungs. There is currently no cure for IPF; therefore, there is an urgent need to identify novel therapeutic targets that can prevent the progression of IPF. Compelling evidence indicates that the second messenger, cyclic adenosine monophosphate (cAMP), inhibits lung fibroblast proliferation and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8a6ff1c5-6c1e-5177-9aad-786de10db81c
DOI
10.1101/2024.09.13.612935
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationDOI 10.1101/2024.09.13.612935
Select a neighboring publication to make it the new centre.